Related Experiment Video
Updated: Jun 28, 2026

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
Published on: May 19, 2023
Immunogenicity and safety of an indigenously developed DTPw hepatitis B combination vaccine in Indian infants
Raju Shah1, M B Raghu, A Shivananda
1Department of Pediatrics, Shardaben General Hospital and Smt NHL Municipal Medical College, Ahmedabad, India. rajucshah@gmail.com
Insights
This study found the indigenous Shantetra vaccine (diphtheria, tetanus, pertussis, and hepatitis B) to be safe and effective in Indian infants. It demonstrated high seroprotective immune responses comparable to Tritanrix HB, with similar mild adverse events.
Area of Science:
- Pediatric Vaccinology
- Immunology
- Infectious Disease Prevention
Background:
- Hepatitis B, diphtheria, tetanus, and B. pertussis (pertussis) infections pose significant health risks to infants.
- Effective vaccination strategies are crucial for preventing these diseases in early childhood.
- Indigenous vaccine development is vital for public health accessibility and sustainability.
Purpose of the Study:
- To assess the safety and immunogenicity of an indigenous tetravalent vaccine (Shantetra) against hepatitis B, diphtheria, tetanus, and B. pertussis.
- To compare the efficacy of Shantetra with a licensed comparator vaccine (Tritanrix HBTM) in Indian infants.
Main Methods:
- A multicentric, randomized, single-blind, intention-to-treat study was conducted across five tertiary care centers in India.
- 151 healthy Indian infants were randomized (2:1) to receive either Shantetra or Tritanrix HBTM.
- Humoral immune response, specifically seroconversion rates for each antigenic component, was monitored post-vaccination.
Main Results:
- Shantetra demonstrated high seroprotective rates: 98.9% for diphtheria, tetanus, and hepatitis B components.
- Anti-pertussis antibody response was robust, observed in 89% of infants receiving Shantetra.
- Common adverse events, including injection site pain, mild fever, and transient crying, were similar in both vaccine groups.
Conclusions:
- The indigenously developed DTPw-Hepatitis B combination vaccine (Shantetra) is safe and immunogenic in healthy Indian infants.
- Shantetra provides comparable seroprotective immune responses to the comparator vaccine.
- This study supports the use of indigenously developed vaccines for national immunization programs.
Objective:
To evaluate the safety and immunogenicity of an indigenous hepatitis B, diphtheria, tetanus and B. pertussis tetravalent vaccine (Shantetra) in comparison with Tritanrix HBTM in healthy Indian infants.
Design:
Multicentric, randomized, single blind intention-to-treat study with 12-18 weeks of follow up period.
Setting:
5 out patient departments at tertiary care referral centers across India.
Participants:
151 infants were randomized in a 2:1 ratio to recruit 101 in the Shantetra and 50 in the Tritanrix HBTM groups respectively. A total of 136 subjects completed the study. No patients were withdrawn from the study due to any adverse effects.
Interventions:
Recruited subjects were randomized to receive three doses of either of the two DTPw-Hepatitis B combination vaccines as per the EPI schedule.
Main Outcome Measures:
Monitoring the humoral immune response (seroconversion rates) induced by each antigenic component three to six weeks after the last dose of vaccine in both the groups.
Results:
Seroprotective immune response was observed in 98.9% subjects for diphtheria, tetanus and hepatitis B components in the Shantetra group as compared to 95.5% subjects in the Tritanrix HB group. Anti pertussis antibody response was seen in 89% and 91.1% in the Shantetra and Tritanrix HB groups, respectively. The commonly observed adverse events in both the groups were, pain at injection site, mild fever and transient crying.
Conclusion:
The safety and immunogenicity of indigenously developed DTPwHepatitis B combination vaccine was demonstrated in the present study.
More Related Videos
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Poliomyelitis
Vaccines